MEDICAL CITY WEATHERFORD HOSPITAL
713 East Anderson Street, Weatherford, TX · Medicalcityhealthcare · · NPI 1417471467
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj, lidocaine w epinephrine HCPCS J2004 | $4.86 | $4.86 | $0.03 – $0.07 | 3 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $6.34 – $63.10 | 4 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $5,366,638.33 – $5,366,638.33 | 1 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $318.85 – $1,991.38 | 4 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $38.59 – $136.21 | 3 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $4,994.22 – $7,741.80 | 2 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $83.28 – $306.85 | 3 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $10.76 – $19.36 | 2 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $143.45 – $5,828.83 | 5 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $64.86 – $377.16 | 3 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $1,919.75 – $1,919.75 | 1 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $773.80 – $4,766.92 | 4 |
| Inj menotropins 75 iu HCPCS S0122 | not published | not published | $379.29 – $1,558.19 | 3 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $133.26 | $133.26 | $3.63 – $23.11 | 5 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $2.09 – $12.59 | 4 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $3.60 – $13.74 | 3 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.60 – $9.80 | 4 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $6.90 – $10.23 | 2 |
| Inj, micafungin (par pharm) HCPCS J2247 | not published | not published | $0.31 – $2.18 | 4 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $47.57 – $292.08 | 4 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $243.63 – $1,503.67 | 4 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $25.22 – $152.61 | 4 |
| Inj, moxifloxacin 100 mg HCPCS J2280 | not published | not published | $8.57 – $72.40 | 5 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $7.10 – $46.96 | 4 |
| Inj multihance HCPCS A9577 | not published | not published | $1.82 – $14.59 | 6 |
| Inj multihance multipack HCPCS A9578 | not published | not published | $1.81 – $14.02 | 6 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.31 – $4.97 | 4 |
| Inj naloxone hydrochloride HCPCS J2310 | not published | not published | $9.21 – $164.75 | 3 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $641.83 – $4,150.44 | 4 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | not published | not published | $659.50 – $818.10 | 3 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | $48.11 | $48.11 | $3.58 – $12.10 | 3 |
| Inj nivolumab 2 mg hyaluron HCPCS J9289 | not published | not published | $45.87 – $160.23 | 3 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.58 – $569.52 | 4 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $709.01 – $2,083.05 | 9 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $709.01 – $2,083.05 | 9 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $1.65 – $3.21 | 3 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $45.19 – $285.85 | 4 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $3,407.46 – $6,334.97 | 3 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | not published | not published | $41.88 – $249.30 | 5 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $46.82 – $312.81 | 4 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $170.81 – $365.12 | 3 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $1.35 – $7.99 | 2 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $381.24 – $2,383.00 | 4 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $10.76 – $23.48 | 3 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $3.87 – $24.75 | 4 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $4,271,819.03 – $4,271,819.03 | 1 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $28.74 – $355.49 | 4 |
| Inj, pafolacianine, 0.1 mg HCPCS A9603 | not published | not published | $456.40 – $819.73 | 2 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $3.76 – $356.04 | 4 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | not published | not published | $6.24 – $40.12 | 3 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $70.43 – $450.56 | 4 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $526.94 – $3,411.49 | 5 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $99.04 – $604.01 | 4 |
| Inj, pedmark, 100 mg HCPCS J0208 | $552.10 | $552.10 | $158.52 – $563.71 | 3 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $143.99 – $858.70 | 4 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $24.71 – $1,218.54 | 4 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $61.89 – $218.38 | 3 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $46.35 – $319.13 | 4 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.74 – $58.94 | 4 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $134.03 – $503.93 | 3 |
| Inj pemetrexed (bluepoint) HCPCS J9322 | not published | not published | $17.49 – $56.21 | 3 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $0.21 – $62.57 | 4 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $3.86 – $40.19 | 4 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.74 – $35.19 | 4 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $8.37 – $68.10 | 4 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $6,583.50 – $39,193.42 | 4 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $40.54 – $484.69 | 4 |
| Inj perflexane lip micros,ml HCPCS Q9955 | not published | not published | $80.18 – $94.79 | 2 |
| Inj peritoneal venous shunt CPT 49427 | not published | not published | $330.72 – $330.72 | 1 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $12.15 – $73.46 | 4 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $57.17 – $223.89 | 3 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.57 – $21.60 | 4 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $151.35 – $534.12 | 3 |
| Inj proc ankle arthr CPT 27648 | not published | not published | $787.55 – $787.55 | 1 |
| Inj proc elbow arthro CPT 24220 | not published | not published | $603.92 – $603.92 | 1 |
| Inj proc for lymphang CPT 38790 | not published | not published | $592.68 – $592.68 | 1 |
| Inj proc lumbr disk ea lvl CPT 62290 | not published | not published | $1,065.26 – $1,065.26 | 1 |
| Inj proc myelogram lumbar CPT 62284 | not published | not published | $695.70 – $695.70 | 1 |
| Inj proc sialogram CPT 42550 | not published | not published | $495.18 – $495.18 | 1 |
| Inj progesterone per 50 mg HCPCS J2675 | not published | not published | $0.66 – $10.80 | 5 |
| Inj prohance multipack HCPCS A9576 | not published | not published | $1.43 – $11.23 | 6 |
| Inj protirelin per 250 mcg HCPCS J2725 | not published | not published | $131.79 – $186.00 | 2 |
| Inj recombin esperoct per iu HCPCS J7204 | not published | not published | $2.14 – $13.68 | 4 |
| Inj, releuko 1 mcg HCPCS Q5125 | not published | not published | $0.43 – $2.62 | 4 |
| Inj retacrit esrd on dialysi HCPCS Q5105 | not published | not published | $0.71 – $8.37 | 5 |
| Inj retro urethrocysto CPT 51610 | not published | not published | $292.30 – $292.30 | 1 |
| Inj, rimabotulinumtoxinb HCPCS J0587 | not published | not published | $13.00 – $86.06 | 5 |
| Inj roctavian ml 2x10^13vc g HCPCS J1412 | not published | not published | $20,713.62 – $38,925.69 | 2 |
| Inj., rolapitant, 0.5 mg HCPCS J2797 | not published | not published | $3.07 – $5.45 | 2 |
| Inj romidepsin non-lyo 0.1mg HCPCS J9318 | not published | not published | $47.06 – $172.57 | 3 |
| Inj, rykindo, 0.5 mg HCPCS J2801 | not published | not published | $21.50 – $75.88 | 3 |
| Inj scleros sol mult veins CPT 36471 | not published | not published | $116.28 – $410.41 | 9 |
| Inj scleros sol sgl vein CPT 36470 | not published | not published | $70.60 – $410.41 | 9 |
| Inj, sculptra, 0.5mg HCPCS Q2028 | not published | not published | $2.24 – $4.08 | 4 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $891.13 – $3,743.25 | 4 |
| Inj secretin synthetic human HCPCS J2850 | not published | not published | $66.73 – $254.99 | 4 |
| Inj secukinumab intrav 1mg HCPCS J3247 | not published | not published | $17.73 – $107.95 | 4 |
| Inj, sezaby, 1 mg HCPCS J2561 | not published | not published | $1.95 – $8.23 | 3 |
| Inj, spesolimab-sbzo, 1 mg HCPCS J1747 | not published | not published | $61.43 – $397.73 | 4 |
| Inj(s) sclerosant spider veins limb/trunk CPT 36468 | not published | not published | $256.85 – $410.41 | 2 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.